Double valve replacement in a case of Hedinger syndrome [PDF]
Clinical Case Reports, 2023 Hedinger Syndrome or carcinoid heart disease is a rare cardiac complication of neuroendocrine tumors (NET) affecting the tricuspid and pulmonary valves.
Presheet Pathare +2 more
doaj +9 more sources
Hedinger Syndrome—Lessons Learnt: A Single-Center Experience [PDF]
Journal of Cardiovascular Development and Disease, 2023 Background: Hedinger syndrome (HS) or carcinoid heart disease (CD) is a rare and challenging manifestation of malignant neuroendocrine tumours (NETs) involving the heart.
Mohamed El Gabry +6 more
doaj +11 more sources
Hedinger Syndrome with Intraoperative Carcinoid Crisis — Understanding the Pathophysiology for a Successful Management [PDF]
Brazilian Journal of Cardiovascular Surgery, 2021 Carcinoid tumors can be a cause for right heart valve disease, also known as Hedinger syndrome or carcinoid heart disease. Proper understanding of the pathophysiology is of the uttermost importance for adequate treatment of these patients, especially ...
Albert Franz Guerrero-Becerra +4 more
doaj +7 more sources
Hedinger Syndrome: A Rare Cardiac Manifestation of Carcinoid Syndrome [PDF]
Cureus, 2022 Carcinoid syndrome can cause desmoplastic reactions to nearby tissues. When it involves the heart, it causes carcinoid heart disease (CHD) or Hedinger syndrome and usually involves the right-sided heart valves, causing tricuspid insufficiency and pulmonary stenosis (TIPS) and eventually leading to right-sided heart failure.
Ghukasyan H.
exaly +4 more sources
Hedinger syndrome: first experience and two-year follow-up in patients with carcinoid heart disease [PDF]
Journal of Thoracic Disease, 2019 Carcinoid heart disease (CHD) (Hedinger syndrome) is a rare manifestation, it has been described in up to 60% of patients with both neuroendocrine tumors (NETs) and carcinoid syndrome (CS) which, typically inducing right heart-sided abnormalities.Between 07/15 and 10/18, six patients (mean age 63±12 years; 3 females) presented with manifested (NYHA III-
Matthias Thielmann +2 more
exaly +5 more sources
Hedinger syndrome due to advanced malignant neuroendocrine tumour [PDF]
European Heart Journal - Case Reports, 2023 Ansgar Ackerschott
exaly +4 more sources
Ablation of typical atrial flutter as therapeutic component in carcinoid heart disease: a case report [PDF]
Journal of Medical Case Reports, 2022 Background Carcinoid heart disease is the cardiac manifestation of carcinoid syndrome. There is limited research on rhythm management in patients with carcinoid heart disease.
Susann Groschke +6 more
doaj +2 more sources
Right and Left-Sided Carcinoid Heart Disease in the Setting of Selective Serotonin Reuptake Inhibitor Use [PDF]
JACC: Case Reports, 2020 Carcinoid heart disease is a complication of carcinoid syndrome. The role of selective serotonin reuptake inhibitors in carcinoid heart disease is unclear. We present a case of refractory heart failure due to right- and left-sided carcinoid heart disease
Jennifer Bell, MD +4 more
doaj +2 more sources
Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort [PDF]
BMC Cancer, 2023 Background Carcinoid heart disease is a rare disease which develops in patients with functional neuroendocrine tumors in an advanced tumor state. Patients diagnosed with carcinoid heart disease have a poor longtime prognosis with respect to morbidity and
Eva Grundmann +3 more
doaj +2 more sources
The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy [PDF]
Frontiers in EndocrinologyIntroductionPatients with pancreatic neuroendocrine neoplasms (P-NEN) may benefit from peptide receptor radionuclide therapy (PRRT). Prediction of overall survival (OS) using statistical models has the potential to guide treatment decisions.
Aviral Singh +7 more
doaj +2 more sources